Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fransiscus E Utama

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
The Biochemical Journal|June 18, 2003
Phosphorylation of BATF regulates DNA binding: a novel mechanism for AP-1 (activator protein-1) regulationChristopher D Deppmann, Tina M Thornton, Fransiscus E Utama, et al.
Endocrinology|November 22, 2008
Insensitivity of human prolactin receptors to nonhuman prolactins: relevance for experimental modeling of prolactin receptor-expressing human cellsFransiscus E Utama, Thai H Tran, Amy Ryder, et al.
Cancer Research|March 3, 2007
Insulin receptor substrate-1 regulates the transformed phenotype of BT-20 human mammary cancer cellsOzlem Dalmizrak, An Wu, Jia Chen, et al.
Nature Methods|June 24, 2005
Ultrahigh density microarrays of solid samplesMatthew J LeBaron, Heidi R Crismon, Fransiscus E Utama, et al.
The American Journal of Pathology|October 19, 2010
PTP1B suppresses prolactin activation of Stat5 in breast cancer cellsKevin J Johnson, Amy R Peck, Chengbao Liu, et al.
Cancer Research|February 4, 2010
Prolactin inhibits BCL6 expression in breast cancer through a Stat5a-dependent mechanismThai H Tran, Fransiscus E Utama, Justin Lin, et al.
Cancer Research|July 18, 2008
Cyclin D1b is aberrantly regulated in response to therapeutic challenge and promotes resistance to estrogen antagonistsYing Wang, Jeffry L Dean, Ewan K A Millar, et al.
Breast Cancer Research : BCR|September 6, 2013
Prolactin-Stat5 signaling in breast cancer is potently disrupted by acidosis within the tumor microenvironmentNing Yang, Chengbao Liu, Amy R Peck, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 12, 2018
Loss of Nuclear Localized Parathyroid Hormone-Related Protein in Primary Breast Cancer Predicts Poor Clinical Outcome and Correlates with Suppressed Stat5 SignalingThai H Tran, Fransiscus E Utama, Takahiro Sato, et al.
Science Advances|September 15, 2021
NSG-Pro mouse model for uncovering resistance mechanisms and unique vulnerabilities in human luminal breast cancersYunguang Sun, Ning Yang, Fransiscus E Utama, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The Biochemical Journal|June 18, 2003
Phosphorylation of BATF regulates DNA binding: a novel mechanism for AP-1 (activator protein-1) regulationChristopher D Deppmann, Tina M Thornton, Fransiscus E Utama, et al.
Endocrinology|November 22, 2008
Insensitivity of human prolactin receptors to nonhuman prolactins: relevance for experimental modeling of prolactin receptor-expressing human cellsFransiscus E Utama, Thai H Tran, Amy Ryder, et al.
Cancer Research|March 3, 2007
Insulin receptor substrate-1 regulates the transformed phenotype of BT-20 human mammary cancer cellsOzlem Dalmizrak, An Wu, Jia Chen, et al.
Nature Methods|June 24, 2005
Ultrahigh density microarrays of solid samplesMatthew J LeBaron, Heidi R Crismon, Fransiscus E Utama, et al.
The American Journal of Pathology|October 19, 2010
PTP1B suppresses prolactin activation of Stat5 in breast cancer cellsKevin J Johnson, Amy R Peck, Chengbao Liu, et al.
Cancer Research|February 4, 2010
Prolactin inhibits BCL6 expression in breast cancer through a Stat5a-dependent mechanismThai H Tran, Fransiscus E Utama, Justin Lin, et al.
Cancer Research|July 18, 2008
Cyclin D1b is aberrantly regulated in response to therapeutic challenge and promotes resistance to estrogen antagonistsYing Wang, Jeffry L Dean, Ewan K A Millar, et al.
Breast Cancer Research : BCR|September 6, 2013
Prolactin-Stat5 signaling in breast cancer is potently disrupted by acidosis within the tumor microenvironmentNing Yang, Chengbao Liu, Amy R Peck, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 12, 2018
Loss of Nuclear Localized Parathyroid Hormone-Related Protein in Primary Breast Cancer Predicts Poor Clinical Outcome and Correlates with Suppressed Stat5 SignalingThai H Tran, Fransiscus E Utama, Takahiro Sato, et al.
Science Advances|September 15, 2021
NSG-Pro mouse model for uncovering resistance mechanisms and unique vulnerabilities in human luminal breast cancersYunguang Sun, Ning Yang, Fransiscus E Utama, et al.
Pageof 2